image
Cytokinetics, Incorporated CYTK
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 32.94
-7.36 %
$ 3.93 B
Market Cap
-6.46
P/E
INCOME STATEMENT
18.5 M REVENUE
145.34%
Growth Rates
1Year 145.34%
3Years -35.99%
5Years -7.22%
7Years 4.73%
10Years -8.90%
-536 M OPERATING INCOME
-8.07%
Growth Rates
1Year -8.07%
3Years -42.25%
5Years -40.24%
7Years -24.85%
10Years -43.23%
-590 M NET INCOME
-12.03%
Growth Rates
1Year -12.03%
3Years -39.90%
5Years -37.10%
7Years -24.41%
10Years -44.70%
EFFICIENCY
Earnings Waterfall Cytokinetics, Incorporated
image
Revenue 18.5 M
Cost Of Revenue 9.53 M
Gross Profit 8.94 M
Operating Expenses 555 M
Operating Income -536 M
Other Expenses 53.3 M
Net Income -590 M
100m100m00(100m)(100m)(200m)(200m)(300m)(300m)(400m)(400m)(500m)(500m)(600m)(600m)18m(10m)9m(555m)(536m)(53m)(590m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000
REVENUE
Revenue 18.5 7.5 94.6 70.4 55.8 26.9 31.5 13.4 106.4 28.7 46.9 30.6 7.6 4.0 2.6 81.5 12.4 13.6 3.1 8.9 13.4 10.6 11.4 8.5 0
GROSS PROFIT
Cost Of Revenue 9.5 330.1 240.8 159.9 97.0 86.1 89.1 90.3 59.9 46.4 44.4 49.5 35.0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 8.9 (322.6) (146.2) (89.5) (41.1) (59.3) (57.6) (76.9) 46.5 (17.7) 2.5 (18.8) (27.4) 4.0 2.6 81.5 12.4 13.6 3.1 8.9 13.4 10.6 11.4 8.5 0
OPERATING INCOME
Operating Expenses 554.7 173.6 178.0 96.8 52.8 39.6 31.3 36.5 27.8 19.7 17.3 15.1 11.7 50.8 52.2 55.5 69.0 70.1 64.5 53.5 51.9 43.2 35.4 26.9 13.8
Selling, General and Administrative Expenses 215.3 173.6 178.0 96.8 52.8 39.6 31.3 36.5 27.8 19.7 17.3 15.1 11.7 13.6 14.2 15.6 15.1 16.7 15.2 13.0 12.0 9.2 7.0 5.9 3.4
Research and Development Expenses 329.9 0 6.6 159.9 97.0 86.1 89.1 90.3 59.9 46.4 44.4 49.5 35.0 37.2 38.0 39.8 54.0 53.4 49.2 40.6 39.9 34.0 28.4 21.0 10.4
Operating Income (536.2) (496.2) (324.2) (186.3) (93.9) (98.9) (88.9) (113.4) 18.7 (37.4) (14.8) (33.9) (39.1) (48.0) (49.6) 26.1 (59.1) (56.5) (61.3) (44.6) (38.4) (32.6) (24.0) (18.4) (13.8)
PRE-TAX INCOME
Interest Income Expense 86.5 57.7 51.2 29.3 38.7 27.4 21.6 17.0 2.2 94 K 0 0 2 K 0.1 0.2 0.4 0.5 0.7 0.5 0.5 0.5 2.5 1.3 0.4 0.3
Total Other Income (53.3) (30.0) (64.8) (29.0) (33.3) (22.8) (17.4) (14.4) (2.2) 94 K 0.1 0.2 87 K 0.1 0.2 (1.4) 0.2 7.6 4.2 2.4 1.2 0 0 18.4 0
Pre-Tax Income (589.5) (526.2) (389.0) (215.3) (127.3) (121.7) (106.3) (127.8) 16.5 (37.5) (14.6) (33.7) (39.0) (47.9) (49.5) 24.7 (56.4) (48.9) (57.1) (42.3) (37.2) 0 0 0 0
NET INCOME
Tax Provision 0 0 13.6 27.1 36.8 27.4 4.2 0.7 (0.7) (0.6) (0.5) (0.4) (0.7) (0.2) (0.2) 0.1 (0.2) 0 0 0 0 95 K (0.9) 15.9 13.1
Net Income (589.5) (526.2) (402.6) (242.4) (164.1) (149.1) (106.3) (127.8) 16.5 (37.5) (14.6) (33.7) (39.0) (47.9) (49.3) 24.5 (56.4) (48.9) (57.1) (42.3) (37.2) (32.7) (23.1) (15.9) (13.1)
EPS 5.26 5.45 4.48 3.15 2.54 2.59 1.95 2.59 0.41 0.97 0.41 1.24 2.15 4.06 4.61 2.58 6.85 6.16 9.36 8.87 11.3 103 79.5 67.1 81.3